The Lancet 12 Risk Factors
In 2020, the Lancet Commission answered the question every middle-aged adult eventually asks — "what could I actually do about dementia risk?" — with a list of twelve modifiable factors, each with a weight attached. The headline: roughly 40% of dementia worldwide attaches to factors people can in principle change. This page walks the list, explains what the percentages mean and do not mean, and points to the few levers where the evidence for action is strongest.
What the evidence supports
- Twelve modifiable factors carry roughly 40% of dementia risk in the Commission's 2020 synthesis; the 2024 update extends the list to fourteen and the share to about 45%.
- Hearing loss (≈8%) and less education (≈7%) are the two largest single weights; smoking, depression, and social isolation follow.
- Delaying dementia onset by five years would roughly halve the population's case count — delay is the treatment.
What remains uncertain
- The percentages are built from relative risks and prevalence data; factors overlap heavily, so the weights do not simply add up.
- A population-attributable fraction is population math, not a personal forecast — it says nothing about any single person's future.
- Only a few factors have trial-grade evidence that acting on them changes dementia outcomes; the rest rest on observational links.
Evidence last reviewed: August 15, 2026. Conclusions may change as new research is published.
the twelve, weighted
The List, Weighted
The Commission's 2020 report reviewed the world's cohort, case-control, and trial literature and settled on twelve factors it judged modifiable, each with an estimated population-attributable fraction (PAF): the share of dementia cases statistically attached to that factor across a whole population. Grouped by the life stage where each does most of its damage, the list looks like this.
- 🎓 Early life — less education (≈7%). Fewer years of formal schooling in childhood, the original reserve-building window.
- 👂 Midlife — hearing loss (≈8%), head injury (≈3%), hypertension (≈2%), excess alcohol (≈1%), obesity (≈1%). The decades from the forties to the sixties, when vascular and sensory damage compounds quietly.
- 🚬 Later life — smoking (≈5%), depression (≈4%), social isolation (≈4%), physical inactivity (≈2%), diabetes (≈1%), air pollution (≈2%). Factors that keep acting into the sixties and beyond.
Weighted for the overlap between factors — people carrying one risk usually carry several — the twelve sum to about 40% of dementia risk worldwide (Livingston et al., Lancet, 2020). The 2024 update added untreated vision loss and high LDL cholesterol, taking the list to fourteen factors and the modifiable share to roughly 45%.
What 40 Percent Actually Means
The 40% figure is routinely quoted as "40% of dementia is preventable," which is a misreading worth correcting once, precisely:
- 🧮 It is built from averages. A PAF combines how common a factor is with how strongly it links to dementia in populations. Both inputs vary by region, era, and how each factor is measured, which is why the number moved from 35% (nine factors, 2017) to 40% to 45% across reports.
- 🔗 The factors overlap. Hypertension, obesity, diabetes, and inactivity travel together. The weighting corrects for this "communality" but cannot fully untangle it, so the twelve weights overstate what removing any one factor would achieve.
- 🧭 It is not your personal probability. A 40% population share does not mean you personally control 40% of your fate. People with none of the factors develop dementia; people with several often do not.
- 🗓️ And it is a floor, not a ceiling. The list keeps growing as evidence matures — vision loss and LDL cholesterol only made the 2024 cut.
The honest read: treat 40% as a planning number for societies and a prioritization hint for individuals — a map of where the evidence concentrates, not a ledger of your risk. The next section is that map.
🧾 A menu, not a ledger
The percentages rank factors for whole populations. They do not tell you what your hearing or your blood pressure is doing to your brain. The sane reading order: use the list to choose where to act — favouring the factors with actual intervention evidence, which the table below grades — and let trial results, not the weights, set your expectations. Also keep the asymmetry nobody likes: "modifiable in principle" does not mean reversing a factor in middle age fully erases the damage it did earlier.
The Twelve, Ranked
Note the quirk in the ranking: less education sits second at ≈7%, but for a midlife reader it is mostly water under the bridge — schooling happens in childhood, and while adult learning appears to add reserve, the window is not the same. For adults, the actionable top of the list is hearing loss at 8%, which is why the next page in this series (the hearing-loss surprise) treats it as a first-class intervention.
The Midlife Cluster
Five of the twelve factors act mainly in midlife, and the Commission's life staging is not decorative. Midlife is when the vascular system and the sensory system take their longest, quietest damage, with a gap of two decades or more between exposure and symptom. The cluster deserves its own paragraph:
- 👂 Hearing loss — decades of muffled input before anyone notices; the hearing page in this series owns the mechanism and the trial evidence.
- 🫀 Hypertension — midlife blood pressure predicts late-life dementia far better than late-life blood pressure does. The blood-pressure window page covers the SPRINT MIND findings; the Metabolic pillar's page owns blood pressure itself.
- 🍺 Alcohol above 21 UK units per week, and ⚖️ obesity — metabolic insults with long tails, operating in the same midlife decades.
- 🚬 Smoking and 🍬 diabetes — the two factors that straddle life stages, doing damage from midlife onward.
The practical translation: prevention is a midlife project. The forties, fifties, and early sixties are when the modifiable risk does its work — a generation before symptoms appear. That is why late-life interventions tend to show smaller returns, and why the audit you do at fifty matters more than the one at seventy-five.
The Scoreboard, Row by Row
| Factor | Life stage | Est. share | Where the action is | Evidence for action |
|---|---|---|---|---|
| 👂 Hearing loss | Midlife | ≈ 8% | Hearing checks and hearing aids — trial-supported | Strong |
| 🎓 Less education | Early life | ≈ 7% | Mostly fixed in youth; adult learning adds some reserve | Modest |
| 🚬 Smoking | Later life | ≈ 5% | Quitting at any age lowers risk | Strong |
| 😔 Depression | Later life | ≈ 4% | Treating depression and reducing recurrence | Modest |
| 👥 Social isolation | Later life | ≈ 4% | Staying connected; hearing correction helps here too | Modest |
| 🧠 Head injury | Midlife | ≈ 3% | Helmets, fall prevention, safer roads | Modest |
| 🫀 Hypertension | Midlife | ≈ 2% | Midlife blood-pressure control — trial-supported | Strong |
| 🏃 Physical inactivity | Later life | ≈ 2% | Regular exercise, any amount beats none | Strong |
| 🏭 Air pollution | All life | ≈ 2% | Societal policy; limited personal control | Limited |
| 🍺 Excess alcohol | Midlife | ≈ 1% | Staying under 21 UK units per week | Modest |
| ⚖️ Obesity | Midlife | ≈ 1% | Weight management in the midlife decades | Modest |
| 🍬 Diabetes | Later life | ≈ 1% | Prevention and control of diabetes | Modest |
The verdict column grades the evidence that acting on a factor changes dementia risk specifically — not the factor's general health value. On that strict standard, trial-grade support concentrates in four places: hearing correction, blood-pressure control, exercise, and quitting smoking. Everything else on the list is worth doing for other reasons, with dementia as a plausible bonus rather than a promised payout.
Stacking Beats Singletons
There is a pattern in the prevention literature worth knowing before you start pulling levers: single-factor randomized trials keep coming back null (the supplements page documents the worst offenders), while the trial that moved the needle treated several factors at once. FINGER randomized 1,260 at-risk Finnish adults to two years of diet, exercise, cognitive training, and vascular monitoring — and produced a modest but significant cognitive benefit over control (Ngandu et al., Lancet, 2015). The parent topic owns FINGER's details; the lesson here is structural: the twelve factors are a menu for simultaneous action, not a sequence. Replication trials (World-Wide FINGERS) are running on several continents now.
And the operational version of this list already exists on this site: the quarterly audit checks blood pressure, glucose, weight, activity, hearing, and connection on a repeating schedule — the twelve factors, translated into a tracking routine. If you want this page to change your week rather than your worldview, the audit is where the list becomes a calendar.
The Bottom Line
- Twelve factors, roughly 40% of dementia risk — hearing loss (≈8%) and less education (≈7%) lead the weights; the 2024 update says fourteen factors and about 45%.
- The weights are population estimates — built from averages with overlap corrections, a prioritization map rather than a personal ledger.
- Midlife is the window — hearing, blood pressure, alcohol, and obesity do their damage in the forties through sixties, decades before symptoms appear.
- Evidence for action concentrates in four levers — hearing correction, blood-pressure control, exercise, and quitting smoking — and stacking beats singletons.
Related Topics
- Livingston et al., "Dementia prevention, intervention, and care: 2020 report of the Lancet Commission," The Lancet (2020)
- Livingston et al., "Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission," The Lancet (2024)
- Ngandu et al., "A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial," The Lancet (2015)
- Brookmeyer et al., "Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset," American Journal of Public Health (1998)
- Lin et al., "Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss (ACHIEVE): a multicentre, randomised controlled trial," The Lancet (2023)
- Williamson et al., "Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial," JAMA (2019)